Zobrazeno 1 - 10
of 219
pro vyhledávání: '"Takeshi KAWAKAMI"'
Autor:
Xuan Li, Suvratha Jayaprasad, Elisabet Einarsdottir, Steven J. B. Cooper, Alexander Suh, Takeshi Kawakami, Octavio Manuel Palacios-Gimenez
Publikováno v:
Scientific Data, Vol 11, Iss 1, Pp 1-7 (2024)
Abstract Morabine grasshoppers in the Vandiemenella viatica species group, which show karyotype diversity, have been studied for their ecological distribution and speciation in relation to their genetic and chromosomal diversity. They are good models
Externí odkaz:
https://doaj.org/article/baa92806f56e485c873deb0c118bdc92
Autor:
Ari Nishimura, Satoshi Hamauchi, Akifumi Notsu, Kunihiro Fushiki, Kotoe Oshima, Takahiro Tsushima, Takeshi Kawakami, Akiko Todaka, Tomoya Yokota, Hirofumi Yasui, Yusuke Onozawa, Kentaro Yamazaki
Publikováno v:
BMC Palliative Care, Vol 23, Iss 1, Pp 1-8 (2024)
Abstract Background Cancer cachexia is characterized by the loss of body weight (BW) and anorexia. Anamorelin (ANAM) is a selective ghrelin receptor agonist with appetite-enhancing anabolic action. The ONO-7643-05 trial demonstrated that ANAM increas
Externí odkaz:
https://doaj.org/article/24031cc2b865457e8779cfad19401a84
Autor:
Naoki Takahashi, Hirokazu Shoji, Kengo Nagashima, Hiroshi Imazeki, Narikazu Boku, Takeshi Kawakami, Kei Muro, Takeru Wakatsuki, Chie Kudo-Saito, Yukiya Narita, Kai Tsugaru, Yusuke Amanuma, Naohiro Okano, Yoshiyuki Yamamoto, Rika Kizawa, Kazunori Aoki
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 11 (2024)
Background Gastric cancer (GC) is one of the most common and deadly malignant diseases worldwide. Despite revolutionary advances, the therapeutic efficacy of anti-PD1/PDL1 monoclonal antibodies in advanced GC is still low due to the emergence of inna
Externí odkaz:
https://doaj.org/article/d0862983d935473cb6e85adbf0ac9cc5
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 1267-1273 (2023)
The administration of chemotherapy to cancer patients with organ dysfunction raises concerns regarding its safety. The safety profile of patients with organ dysfunction due to rare diseases treated with chemotherapy plus immune checkpoint inhibitor i
Externí odkaz:
https://doaj.org/article/30b67f1fbe7349ecb0accaa891e9f86c
Autor:
Miku Obayashi, Shimpei Otsuka, Ryo Ashida, Katsuhisa Ohgi, Mihoko Yamada, Takeshi Kawakami, Katsuhiko Uesaka, Teiichi Sugiura
Publikováno v:
Surgical Case Reports, Vol 9, Iss 1, Pp 1-6 (2023)
Abstract Background Small bowel cancer (SBC) is a rare malignancy that is often diagnosed at an advanced stage. Palliative chemotherapy is the standard treatment for patients with metastatic SBC. The relevant literature on conversion surgery in patie
Externí odkaz:
https://doaj.org/article/b0b0626aef4648b9b124105b4024ea42
Autor:
Naoki Takahashi, Hirokazu Shoji, Kengo Nagashima, Hiroshi Imazeki, Narikazu Boku, Takeshi Kawakami, Kei Muro, Takeru Wakatsuki, Chie Kudo-Saito, Yukiya Narita, Kai Tsugaru, Yusuke Amanuma, Naohiro Okano, Yoshiyuki Yamamoto, Rika Kizawa, Kazunori Aoki
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/907a904781714c80bf6d47dac396da55
Autor:
Takeshi Kawakami, Akiko Todaka, Kotoe Oshima, Kunihiro Fushiki, Satoshi Hamauchi, Takahiro Tsushima, Tomoya Yokota, Yusuke Onozawa, Hirofumi Yasui, Kentaro Yamazaki
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Nanoliposomal irinotecan plus fluorouracil/leucovorin (5-FU/LV) is a standard second-line therapy for patients with pancreatic cancer. Identification of biomarkers is important to determine appropriate treatment strategies. We inv
Externí odkaz:
https://doaj.org/article/5fb48c9e13754408a9254be9b8e19c05
Autor:
Ari Nishimura, Tomoya Yokota, Satoshi Hamauchi, Yusuke Onozawa, Akifumi Notsu, Fuyuki Sato, Takeshi Kawakami, Hirofumi Ogawa, Tsuyoshi Onoe, Takashi Mukaigawa
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background Postoperative chemoradiotherapy (CRT) is a standard therapy for patients with high-risk factors for head and neck squamous cell carcinoma, including positive margin and extra-nodal extension (ENE). However, the prognostic impact o
Externí odkaz:
https://doaj.org/article/94d907326581400ea18843c41991cac0
Autor:
Takeshi Kawakami, Toshiki Masuishi, Yasuyuki Kawamoto, Hirofumi Go, Kyoko Kato, Ryosuke Kumanishi, Kentaro Sawada, Satoshi Yuki, Kouji Yamamoto, Yoshito Komatsu, Kei Muro, Kunihiro Fushiki, Hiromichi Shirasu, Kentaro Yamazaki
Publikováno v:
Cancer Medicine, Vol 11, Iss 11, Pp 2184-2192 (2022)
Abstract Background The development of chemotherapy and treatment strategies for metastatic colorectal cancer (mCRC) have provided patients with significant survival benefits. Currently, molecular targeting agents and late‐line treatment with regor
Externí odkaz:
https://doaj.org/article/e9af5868077043199486d81cc3b48001
Autor:
Hiroyuki Matsubayashi, Satomi Higashigawa, Yoshimi Kiyozumi, Takuma Oishi, Keiko Sasaki, Hirotoshi Ishiwatari, Kenichiro Imai, Kinichi Hotta, Yohei Yabuuchi, Kazuma Ishikawa, Tatsunori Satoh, Hiroyuki Ono, Akiko Todaka, Takeshi Kawakami, Hiromichi Shirasu, Hirofumi Yasui, Teichi Sugiura, Katsuhiko Uesaka, Hiroyasu Kagawa, Akio Shiomi, Nobuhiro Kado, Yasuyuki Hirashima, Yoshio Kiyohara, Etsuro Bando, Masashi Niwakawa, Seiichiro Nishimura, Takeshi Aramaki, Nobuaki Mamesaya, Hirotsugu Kenmotsu, Yasue Horiuchi, Masakuni Serizawa
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Microsatellite instability (MSI) is a key marker for predicting the response of immune checkpoint inhibitors (ICIs) and for screening Lynch syndrome (LS). Aim This study aimed to see the characteristics of cancers with high level
Externí odkaz:
https://doaj.org/article/653fcffd821146b6a372390718b060f2